RNTX
Rein Therapeutics
RNTX
RNTX
22 hedge funds and large institutions have $2.37M invested in Rein Therapeutics in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
54% less capital invested
Capital invested by funds: $5.2M → $2.37M (-$2.83M)
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$96.3K | |
| 2 | +$91K | |
| 3 | +$29.7K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$8K |
| 5 |
BlackRock
New York
|
+$6.81K |
Top Sellers
| 1 | -$1.47M | |
| 2 | -$864K | |
| 3 | -$309K | |
| 4 |
Jennison Associates
New York
|
-$138K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$67.5K |